TransMedics (TMDX) Gross Profit (2018 - 2026)
TransMedics has reported Gross Profit over the past 8 years, most recently at $93.4 million for Q4 2025.
- For Q4 2025, Gross Profit rose 29.72% year-over-year to $93.4 million; the TTM value through Dec 2025 reached $362.8 million, up 38.43%, while the annual FY2025 figure was $362.8 million, 38.43% up from the prior year.
- Gross Profit for Q4 2025 was $93.4 million at TransMedics, up from $84.6 million in the prior quarter.
- Over five years, Gross Profit peaked at $96.6 million in Q2 2025 and troughed at $3.8 million in Q3 2021.
- A 5-year average of $43.3 million and a median of $38.7 million in 2023 define the central range for Gross Profit.
- Biggest five-year swings in Gross Profit: decreased 25.11% in 2021 and later surged 380.12% in 2022.
- Year by year, Gross Profit stood at $7.0 million in 2021, then soared by 196.35% to $20.7 million in 2022, then surged by 131.48% to $47.9 million in 2023, then surged by 50.27% to $72.0 million in 2024, then grew by 29.72% to $93.4 million in 2025.
- Business Quant data shows Gross Profit for TMDX at $93.4 million in Q4 2025, $84.6 million in Q3 2025, and $96.6 million in Q2 2025.